1. Extracellular serine controls epidermal stem cell fate and tumour initiation.
- Author
-
Baksh SC, Todorova PK, Gur-Cohen S, Hurwitz B, Ge Y, Novak JSS, Tierney MT, Dela Cruz-Racelis J, Fuchs E, and Finley LWS
- Subjects
- Animals, Carcinoma, Squamous Cell metabolism, Cell Differentiation, Cell Transformation, Neoplastic metabolism, Cells, Cultured, Epidermal Cells metabolism, Female, Humans, Male, Mice, Stem Cells metabolism, Carcinoma, Squamous Cell pathology, Cell Transformation, Neoplastic pathology, Epidermal Cells pathology, Ketoglutaric Acids metabolism, Serine metabolism, Stem Cells pathology
- Abstract
Tissue stem cells are the cell of origin for many malignancies. Metabolites regulate the balance between self-renewal and differentiation, but whether endogenous metabolic pathways or nutrient availability predispose stem cells towards transformation remains unknown. Here, we address this question in epidermal stem cells (EpdSCs), which are a cell of origin for squamous cell carcinoma. We find that oncogenic EpdSCs are serine auxotrophs whose growth and self-renewal require abundant exogenous serine. When extracellular serine is limited, EpdSCs activate de novo serine synthesis, which in turn stimulates α-ketoglutarate-dependent dioxygenases that remove the repressive histone modification H3K27me3 and activate differentiation programmes. Accordingly, serine starvation or enforced α-ketoglutarate production antagonizes squamous cell carcinoma growth. Conversely, blocking serine synthesis or repressing α-ketoglutarate-driven demethylation facilitates malignant progression. Together, these findings reveal that extracellular serine is a critical determinant of EpdSC fate and provide insight into how nutrient availability is integrated with stem cell fate decisions during tumour initiation.
- Published
- 2020
- Full Text
- View/download PDF